Your browser doesn't support javascript.
loading
Smoking-Related Interstitial Lung Diseases.
Alarcon-Calderon, Amarilys; Vassallo, Robert; Yi, Eunhee S; Ryu, Jay H.
Afiliação
  • Alarcon-Calderon A; Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine and Science, 200 1st Street, Southwest, Rochester, MN 55905, USA.
  • Vassallo R; Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine and Science, 200 1st Street, Southwest, Rochester, MN 55905, USA.
  • Yi ES; Department of Laboratory Medicine & Pathology, Mayo Clinic College of Medicine and Science, 200 1st Street, Southwest, Rochester, MN 55905, USA.
  • Ryu JH; Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine and Science, 200 1st Street, Southwest, Rochester, MN 55905, USA. Electronic address: Ryu.jay@mayo.edu.
Immunol Allergy Clin North Am ; 43(2): 273-287, 2023 05.
Article em En | MEDLINE | ID: mdl-37055089
Smoking-related interstitial lung diseases (ILDs) are a group of heterogeneous, diffuse pulmonary parenchymal disease processes associated with tobacco exposure. These disorders include pulmonary Langerhans cell histiocytosis, respiratory bronchiolitis-associated ILD, desquamative interstitial pneumonia, acute eosinophilic pneumonia, and combined pulmonary fibrosis and emphysema. This review summarizes the current evidence of pathogenesis, clinical manifestations, diagnostic approach, prognosis, and treatment modalities for these diseases. We also discuss the interstitial lung abnormalities incidentally detected in radiologic studies and smoking-related fibrosis identified on lung biopsies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bronquiolite / Doenças Pulmonares Intersticiais Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bronquiolite / Doenças Pulmonares Intersticiais Idioma: En Ano de publicação: 2023 Tipo de documento: Article